CNC · Centene Corporation Q2 FY2026 earnings call record财报电话会记录

“Thanks to strong first-half results, we now expect full year 2026 adjusted diluted earnings per share of greater than $4.80, up from our prior outlook of greater than $3.40 provided during our April update.”

“As this business hits post IRA stability, we look forward to delivering consistent margin on what is now roughly $25 billion of premium revenue and successfully leveraging our greater than $60 billion in pharmacy spend through our partnership with ESI to deliver industry-leading cost structure to our state customers and members across lines of business.”

“Today, we reported very strong second quarter 2026 results, including $44.4 billion in premium and service revenue and adjusted diluted earnings per share of $2.51.”

“About $180 million related to Marketplace final 2025 risk adjustment, net favorability relative to our prior guidance, and about $160 million in our Medicare segment, largely favorable PDP 2025 risk adjustment and quality settlements.”

“These actions, including further digitization, more ubiquitous use of technology and AI, and improvements in the customer experience alongside operational efficiencies, should help us not just adapt to volume changes in our business, but also drive margin restoration over the next few years.”

“Cash flow provided by operations was $8 billion year-to-date and $3.6 billion for Q2, primarily driven by net earnings and the net impact of temporary passthrough payment receipts, state premium payments, and Marketplace-related payments to CMS.”

“Again, I'll sort of tick through a couple of things that I think are helpful to think about and the things that we're thinking about as we approach kind of planning for 2027, guiding for 2027, that give us a sense of confidence in terms of, again, that goal of continued margin progression through the headwinds of OB3.”

“First, your 10-Q indicates the 2025 risk adjustment settlement benefited the company by $481 million for the year.”

“If you think about the 71 rate cohort, a few of those states did put in explicit factors for the OB3 implementation, but all of them have committed to looking at those rates 1/1/2027 and thinking about mid-cycle adjustments as we step into the year when those impacts are going to come.”

“Once we get to back half of 2027, I think what we will start to see is the ability to impact underlying trend, have the benefit of the tailwind of rates from the base period, and then the benefit of explicit adjustments in the forward-looking rates relative to OB3.”

“The $180 million is about 60 basis points on the full year, but there's some additional improvement in there, and you sort of have to look at these in tandem, both from the improvement relative to prior guidance in our relative risk position.”

“Coming out of sort of the back half of 2025 and coming into 2026, you heard us talk a lot about our focus on multi-year margin restoration for the business and also a view that there was an opportunity in this moment, for a lot of different reasons, to really optimize the enterprise for what we see in the future.”